Scott T. Benken
Clinical Associate Professor, College of Pharmacy
Email:
Related Sites:
Undergrad Resrch Pharm Pract (PMPR 380), 8/23/2021 – 12/3/2021
PhLAMES 4 (PHAR 468), 1/11/2021 – 4/30/2021
Undergrad Resrch Pharm Pract (PMPR 380), 8/24/2020 – 12/4/2020
Undergrad Resrch Pharm Pract (PMPR 380), 1/13/2020 – 5/1/2020
Spec Project in Pharm Pract (PMPR 390), 1/13/2020 – 5/1/2020
Honors Seminar A decade of pharmacy experiences: From pharmacy student to pharmacist in the workplace (HON 201), 1/13/2020 – Present
Applied Research Methods and Skill Development (PMPR 385), 1/13/2020 – Present
Principles of Drug Action and Therapeutics (PHAR 510) (PHAR 510), 1/13/2020 – Present
Critical Care I (PMPR 430), 1/1/2020 – Present
Selected Grants
CTA: AST-134 Urine Sample Processing Study: Analysis of Fresh versus Frozen Urine Samples from ICU Subjects, Astute Medical., 11/9/2021 - 6/9/2023, Obligated Amount: $58138; Anticipated Amount: $58138
CTA: VDX 20-1001 Validation of genomic immune-phenotyping profiles in peripheral blood gene signatures to predict risk of kidney transplant rejection, Verici Dx., 5/4/2021 - 9/30/2024, Obligated Amount: $185844; Anticipated Amount: $185844
CTA: COVID19 M20-404 Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate Safety, Pharmacokinetics, & Pharmacodynamics of Single Ascending Doses of ABBV-47D11 in Adults..., AbbVie, Inc.., 4/12/2021 - 12/1/2021, Obligated Amount: $460435; Anticipated Amount: $460435
COVID19 Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP), Global Coalition for Adaptive Research., 3/1/2021 - 2/28/2022, Obligated Amount: $223052; Anticipated Amount: $223052
CTA: Evaluation of Patient Outcomes from the Kidneycare on Renal Allografts Registry (OKRA) Agreement, CareDX., 5/7/2020 - 5/7/2023, Obligated Amount: $297863; Anticipated Amount: $297863
Edoxaban Clearance during in vitro Continuous Renal Replacement Therapy, Daiichi Sankyo Inc., 3/1/2020 - 9/1/2020, Obligated Amount: $66354; Anticipated Amount: $66354
Edoxaban Clearance during in vitro Continuous Renal Replacement Therapy, Daiichi Sankyo Inc., 3/1/2020 - 9/1/2020, Obligated Amount: $66354; Anticipated Amount: $66354
Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients, Merck Sharp & Dohme Corp., 3/1/2020 - 7/31/2022, No Obligated Amount Set; Anticipated Amount: $137232.72
Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients, Merck Sharp & Dohme Corp., 3/1/2020 - 7/31/2022, No Obligated Amount Set; Anticipated Amount: $137232.72
Selected Publications
Andrews, Lauren, Benken, Jamie, Benedetti, Enrico, Nishioka, Hokuto, Dalton, Kaitlyn, Pierce, Dana, Han, Justin, Shin, Bona, Benken, Scott. (2021). 1327: ANGIOTENSIN II IN THE PERIOPERATIVE MANAGEMENT OF HYPOTENSION IN KIDNEY TRANSPLANT RECIPIENTS. Critical Care Medicine, 50, (1), 665-665. doi:10.1097/01.ccm.0000811632.85984.42.
Cucci, Michaelia, Cunningham, Brittany, Newey, Christopher, Benken, Scott, Mullen, Chanda. (2021). 1536: EVALUATION OF BLOOD PRESSURE VARIABILITY IN MODERATE TO SEVERE TRAUMATIC BRAIN INJURIES. Critical Care Medicine, 50, (1), 772-772. doi:10.1097/01.ccm.0000812468.82937.98.
Goldberg, Rachel N, Johns, Kevin, Ye, William, Mucksavage, Jeff J, Quigley, John G, Shapiro, Nancy L, Benken, Scott T, Atal, Neha, Jacobson, Jeffrey R, Kim, Keri S. (2021). Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center. Blood, 138, (Supplement 1), 1956-1956. doi:10.1182/blood-2021-150855.
Posen, Andrew, Benken, Scott, Kaluzna, Stephanie Dwyer, Sabouni, Murrah, Miglo, Jane, Cai, Jiaqi, Gimbar, Renee Petzel. (2021). Poor guideline adherence in a real-world evaluation of hypertensive emergency management. The American Journal of Emergency Medicine, 51, 46-52. doi:10.1016/j.ajem.2021.09.073.
Andrews, Lauren, Benken, Scott, Tan, Xing, Wenzler, Eric. (2021). Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy. BMC Nephrology, 22, (1), 45. doi:10.1186/s12882-021-02248-7.
Durst, Melissa M, Eitzen, Elizabeth A, Benken, Scott T. (2020). Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis. Annals of Pharmacotherapy, 55, (8), 970-979. doi:10.1177/1060028020980727.
Andrews, Lauren, Benken, Scott. (2020). 1261: Impact of Oral Midodrine on IV Vasopressor De-Escalation During Continuous Renal Replacement Therapy. Critical Care Medicine, 49, (1), 636-636. doi:10.1097/01.ccm.0000730932.66404.8c.
Dalton, Kaitlyn, Mucksavage, Jeffrey, Panlilio-Villanueva, Maria, Benken, Scott. (2020). 388: Comparison of End-Tidal CO2 Values in ICU Patients With and Without In-Hospital Cardiac Arrest. Critical Care Medicine, 49, (1), 183-183. doi:10.1097/01.ccm.0000727440.56731.48.
Andrews, Lauren, Benken, Scott, Tan, Xing, Wenzler, Eric. (2020). Pharmacokinetics and Dialytic Clearance of Apixaban During In Vitro Continuous Renal Replacement Therapy. . doi:10.21203/rs.3.rs-58735/v2.
Professional Leadership
Critical Care PRN Programming Committee, American College of Clinical Pharmacy, 12/1/2020 - Present
Critical Care Prep Course Planning Committee, American College of Clinical Pharmacy, 7/1/2020 - Present
American College of Clinical Pharmacy - Clinical Research Challenge Reviewer, American College of Clinical Pharmacy, 2/1/2018 - Present
Chicagoland Critical Care Conference, University of Illinois at Chicago College of Pharm, 12/1/2015 - Present
SCCM - Clinical Pharmacy and Pharmacology Section Communications Committee, Society of Critical Care Medicine, 1/1/2015 - Present
Notable Honors
2021, Student Preceptor of the Year (Class of 2021),
Education
Degrees:
Pharm.D., University of Cincinnati, United States, 2008
Pharmacy Prerequisite Coursework, Wake Forest University, United States, 2004
Postgraduate Training:
ASHP-Accredited PGY2 Residency in Critical Care Pharmacy, University of Illinois Hospital & Health Sciences System, United States, 2010
ASHP-Accredited PGY1 Pharmacy Practice Residency, University of Illinois Hospital & Health Sciences System, United States, 2009
Licensures and Certifications
Added Qualifications (AQ) – Cardiology, American Pharmacists Association, 4/1/2015 - Present
Board-Certified Pharmacotherapy Specialist, American Pharmacists Association, 12/1/2011 - Present
Advanced Cardiac Life Support, American Heart Association, 1/1/2008 - Present
Basic Life Support, American Heart Association, 1/1/2008 - Present
Selected Presentations
Gimbar, Renee, Dwyer, stephanie, Benken, sc, posen, drew. (2020 December 07). Evaluating Guideline Adherence in the Early Management of Hypertensive Emergency. ASHP Midyear Clinical Meeting. Virtual.